🇺🇸 FDA
Pipeline program

ThisCART19A

ThisCART19A Ph+ALL

Phase 1 small_molecule active

Quick answer

ThisCART19A for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials